A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow ...

HealthDay News — The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Detailed price information for Senseonics Holdings (SENS-A) from The Globe and Mail including charting and trades.

Complications caused by type 1 diabetes can be spotted years before they develop thanks to data from continuous glucose monitors, new evidence has suggested. Researchers from the University of ...

We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® Continuous Glucose Monitoring Systems ...

Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it has filed for CE Mark registration for the Eversense ® 365 CGM system. Eversense 365 is the ...